Juergen Roland Roemisch

Title: Juergen Roland Roemisch: Innovator in Coagulation Factor Xa Preparation

Introduction

Juergen Roland Roemisch is a notable inventor based in Gramatneusiedl, Austria. He has made significant contributions to the field of biochemistry, particularly in the preparation of high-purity coagulation factors. His work is essential for advancements in medical treatments related to blood coagulation.

Latest Patents

Juergen Roemisch holds a patent for the "FX activation process and its use in the preparation of a FXa composition." This invention focuses on a high-purity preparation of Coagulation Factor Xa (FXa) and outlines an activation and purification process that achieves high purity and a high degree of activation without the need for proteinaceous activators during manufacturing. This innovation is crucial for improving the efficacy and safety of coagulation therapies.

Career Highlights

Roemisch is associated with Octapharma AG, a leading company in the development of human proteins for treating various medical conditions. His expertise in coagulation factors has positioned him as a key player in the biopharmaceutical industry. His work has contributed to the advancement of therapeutic options for patients with coagulation disorders.

Collaborations

Juergen Roemisch collaborates with talented professionals in his field, including Katharina Pock and Petra Schulz. These collaborations enhance the research and development efforts at Octapharma AG, fostering innovation and improving patient outcomes.

Conclusion

Juergen Roland Roemisch is a distinguished inventor whose work in the preparation of coagulation factors has made a significant impact in the medical field. His patent for the FX activation process exemplifies his commitment to advancing healthcare solutions. His contributions continue to influence the development of effective treatments for coagulation disorders.